MaxCyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MaxCyte and other ETFs, options, and stocks.

About MXCT

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. 

CEO
Maher Masoud
CEOMaher Masoud
Employees
114
Employees114
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
1998
Founded1998
Employees
114
Employees114

MXCT Key Statistics

Market cap
237.09M
Market cap237.09M
Price-Earnings ratio
-5.63
Price-Earnings ratio-5.63
Dividend yield
—
Dividend yield—
Average volume
839.29K
Average volume839.29K
High today
$2.30
High today$2.30
Low today
$2.22
Low today$2.22
Open price
$2.24
Open price$2.24
Volume
158.50K
Volume158.50K
52 Week high
$5.20
52 Week high$5.20
52 Week low
$2.00
52 Week low$2.00

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MXCT. This list is generated using Robinhood data, and it’s not a recommendation.
ChargePoint
SoFi Technologies
Plug Power
Bionano Genomics
IonQ
Lucid Group
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.